Stockscreener 앱 받기
33.63
1.18%
-0.40
시간 외 거래:
33.63
전일 마감가:
$34.03
열려 있는:
$33.74
하루 거래량:
2.01M
Relative Volume:
0.87
시가총액:
$5.12B
수익:
$3.44B
순이익/손실:
$-8.30M
주가수익비율:
-226.16
EPS:
-0.1487
순현금흐름:
$43.30M
1주 성능:
-4.05%
1개월 성능:
-13.24%
6개월 성능:
+1.39%
1년 성능:
-27.96%
1일 변동 폭
$33.37
$34.64
1주일 범위
$32.37
$35.91
52주 변동 폭
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
명칭
Bruker Corp
전화
978663-3660
주소
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
33.63 | 5.18B | 3.44B | -8.30M | 43.30M | -0.1487 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | 개시 | Goldman | Sell |
| 2025-11-20 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Buy |
| 2024-12-10 | 개시 | UBS | Neutral |
| 2024-12-05 | 업그레이드 | Goldman | Sell → Neutral |
| 2024-10-15 | 개시 | Barclays | Overweight |
| 2024-09-30 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2022-10-21 | 개시 | UBS | Buy |
| 2022-08-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2021-02-05 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 개시 | Goldman | Sell |
| 2020-11-16 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | 다운그레이드 | Cleveland Research | Buy → Neutral |
| 2020-04-02 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | 다운그레이드 | Needham | Strong Buy → Hold |
| 2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2019-06-24 | 재확인 | Needham | Strong Buy |
| 2019-06-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-30 | 개시 | Wolfe Research | Peer Perform |
| 2019-05-06 | 재확인 | Needham | Strong Buy |
| 2019-05-03 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | 업그레이드 | UBS | Sell → Neutral |
| 2019-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 재확인 | BTIG Research | Buy |
| 2019-01-03 | 개시 | Needham | Strong Buy |
모두보기
Bruker Corp 주식(BRKR)의 최신 뉴스
Assessing Bruker (BRKR) Valuation After Steep Multi‑Period Share Price Declines - Yahoo Finance
Will Bruker (BRKR) be Able to Rebound? - Yahoo Finance
Bruker (NASDAQ: BRKR) EVP Mark Munch exercises options and sells 2,000 shares - Stock Titan
Bruker Corporation $BRKR Shares Purchased by Aquatic Capital Management LLC - MarketBeat
Bruker Corp Stock (ISIN: US1167941087) Faces Rising Short Interest Amid Investor Scrutiny - AD HOC NEWS
Callodine Capital Management LP Makes New $1.11 Million Investment in Bruker Corporation $BRKR - MarketBeat
Mark R Munch reports multiple share sales (BRKR) under Rule 144 - Stock Titan
Bruker Corp (BRKR) Trading Down 3.62% on Mar 13 - GuruFocus
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics and Performance Challenges - Markets Mojo
Bruker Makes Acquisitions; LeddarTech Added to Nasdaq: Week in Brief: 1/5/24 - Photonics Spectra
Natixis Advisors LLC Boosts Stock Position in Bruker Corporation $BRKR - MarketBeat
Bruker Corporation $BRKR Position Increased by Ceredex Value Advisors LLC - MarketBeat
Is Bruker (BRKR) Quietly Recasting Its Competitive Moat With Spatial Biology And Proteomics Upgrades? - simplywall.st
These analysts cut their forecasts on Bruker following Q4 results - MSN
Citigroup Inc. Sells 29,083 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corporation $BRKR Shares Acquired by Rhenman & Partners Asset Management AB - MarketBeat
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know - Finviz
RSI Alert: Bruker (BRKR) Now Oversold - Nasdaq
Orbis group reports 16.13M shares in Bruker (BRKR) as 10.6% ownership - Stock Titan
Research Tools & Consumables Stocks Q4 In Review: Bruker (NASDAQ:BRKR) Vs Peers - Yahoo Finance
Bruker Corp To Go Ex-Dividend On March 23rd, 2026 With 0.05 USD Dividend Per Share - 富途牛牛
BRKRP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BRKR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $49 - 富途牛牛
Artisan Partners Limited Partnership Invests $13.69 Million in Bruker Corporation $BRKR - MarketBeat
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Assessing Bruker (BRKR) Valuation After New Spatial Biology Platforms And Collaboration Updates - simplywall.st
BRKR PE Ratio & Valuation, Is BRKR Overvalued - Intellectia AI
Beyond the Balance Sheet: What SWOT Reveals About Bruker Corp (B - GuruFocus
Bruker (NASDAQ: BRKR) outlines 2025 business segments, risks and $2.57B backlog - Stock Titan
Bruker (BRKR): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics With the Launch of CellScape XR - 富途牛牛
Is Bruker (BRKR) Now Offering Value After A Prolonged Share Price Slump? - Yahoo Finance
Bruker Corporation (NASDAQ:BRKR) Given Average Rating of "Hold" by Brokerages - MarketBeat
New Bruker tool targets 3,000-patient tumor study in spatial proteomics - Stock Titan
Is Bruker (BRKR) Now Attractive After A 21% One Year Share Price Decline? - simplywall.st
Reasons Why Bruker Corporation (BRKR) Appears So Attractive - Finviz
Inside Bruker and Noetik’s push toward 1B mapped human cells - Stock Titan
Bruker unveils spatial biology platforms at AGBT conference - Investing.com
Bruker unveils spatial biology platforms at AGBT conference By Investing.com - Investing.com Canada
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology – Company AnnouncementFT.com - Financial Times
Inside Bruker’s new tools to map cancer and cells in 3D space - Stock Titan
Bruker announces board changes and declares quarterly dividend By Investing.com - Investing.com South Africa
Bruker announces board changes and declares quarterly dividend - Investing.com
Envestnet Asset Management Inc. Sells 43,490 Shares of Bruker Corporation $BRKR - MarketBeat
3D Protein Structure Analysis Market Report 2026 Featuring - GlobeNewswire
3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players - Yahoo Finance UK
The Top 5 Analyst Questions From Bruker's Q4 Earnings Call - Finviz
Nasdaq Analyst Becomes Optimistic; Check Out the Top 5 Upgrades for Thursday - Intellectia AI
The Top 5 Analyst Questions From Bruker’s Q4 Earnings Call - Yahoo Finance
Bruker (BRKR) executive exercises options and sells 2,000 shares - Stock Titan
Bruker Corp (BRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):